Citadel Advisors’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,971
| Closed | -$206K | – | 13814 |
|
|
2025
Q4 | $206K | Sell |
10,971
-11,204
| -51% | -$169K | ﹤0.01% | 10984 |
|
|
2025
Q3 | $283K | Sell |
22,175
-85,020
| -79% | -$1.28M | ﹤0.01% | 10503 |
|
|
2025
Q2 | $1.8M | Sell |
107,195
-75,176
| -41% | -$1.02M | ﹤0.01% | 5901 |
|
|
2025
Q1 | $2.33M | Buy |
182,371
+81,449
| +81% | +$1.31M | ﹤0.01% | 5244 |
|
|
2024
Q4 | $1.78M | Buy |
100,922
+25,405
| +34% | +$482K | ﹤0.01% | 5875 |
|
|
2024
Q3 | $1.73M | Sell |
75,517
-56,925
| -43% | -$1.29M | ﹤0.01% | 5816 |
|
|
2024
Q2 | $3.04M | Buy |
+132,442
| New | +$4.08M | ﹤0.01% | 4543 |
|
|
2023
Q1 | – | Sell |
-13,656
| Closed | -$509K | – | 15235 |
|
|
2022
Q4 | $509K | Sell |
13,656
-11,752
| -46% | -$455K | ﹤0.01% | 8198 |
|
|
2022
Q3 | $1.01M | Buy |
25,408
+4,784
| +23% | +$177K | ﹤0.01% | 6972 |
|
|
2022
Q2 | $790K | Buy |
20,624
+11,969
| +138% | +$433K | ﹤0.01% | 7572 |
|
|
2022
Q1 | $343K | Sell |
8,655
-14,593
| -63% | -$571K | ﹤0.01% | 10287 |
|
|
2021
Q4 | $965K | Buy |
23,248
+14,445
| +164% | +$628K | ﹤0.01% | 8055 |
|
|
2021
Q3 | $371K | Buy |
8,803
+1,566
| +22% | +$78.9K | ﹤0.01% | 10574 |
|
|
2021
Q2 | $332K | Sell |
7,237
-17,954
| -71% | -$854K | ﹤0.01% | 11024 |
|
|
2021
Q1 | $1.18M | Buy |
25,191
+813
| +3% | +$39.5K | ﹤0.01% | 7687 |
|
|
2020
Q4 | $1.04M | Buy |
24,378
+7,118
| +41% | +$365K | ﹤0.01% | 6724 |
|
|
2020
Q3 | $850K | Buy |
+17,260
| New | +$955K | ﹤0.01% | 6328 |
|
|
2020
Q2 | – | Sell |
-16,651
| Closed | -$758K | – | 10275 |
|
|
2020
Q1 | $758K | Buy |
16,651
+7,839
| +89% | +$471K | ﹤0.01% | 5796 |
|
|
2019
Q4 | $581K | Sell |
8,812
-6,647
| -43% | -$406K | ﹤0.01% | 6582 |
|
|
2019
Q3 | $893K | Buy |
15,459
+741
| +5% | +$45.9K | ﹤0.01% | 5786 |
|
|
2019
Q2 | $848K | Buy |
14,718
+8,144
| +124% | +$377K | ﹤0.01% | 5962 |
|
|
2019
Q1 | $254K | Sell |
6,574
-383
| -6% | -$15K | ﹤0.01% | 7853 |
|
|
2018
Q4 | $265K | Sell |
6,957
-17,468
| -72% | -$671K | ﹤0.01% | 7470 |
|
|
2018
Q3 | $942K | Buy |
24,425
+17,224
| +239% | +$653K | ﹤0.01% | 5664 |
|
|
2018
Q2 | $269K | Buy |
+7,201
| New | +$251K | ﹤0.01% | 7397 |
|
|
2018
Q1 | – | Sell |
-5,365
| Closed | -$200K | – | 8612 |
|
|
2017
Q4 | $200K | Sell |
5,365
-7,907
| -60% | -$281K | ﹤0.01% | 7116 |
|
|
2017
Q3 | $500K | Buy |
+13,272
| New | +$417K | ﹤0.01% | 5323 |
|
|
2016
Q2 | – | Sell |
-14,308
| Closed | -$222K | – | 7207 |
|
|
2016
Q1 | $222K | Buy |
+14,308
| New | +$210K | ﹤0.01% | 5508 |
|
Other funds holding NRC
VCM
QI
Citadel Advisors's NRC Position: Q1 2026 in Review
Citadel Advisors sold out of NRC Health Common Stock (NRC) in Q1 2026, closing a stake of 10,971 shares — an estimated $206K sold.
Citadel Advisors first reported a position in NRC in Q1 2016 and held it in 28 quarters. The position peaked at $3.04M in Q2 2024. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- Citadel Advisors reported no remaining NRC Health Common Stock position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 10,971 NRC Health Common Stock shares in Q1 2026, an estimated $206K.
- Citadel Advisors first reported a position in NRC Health Common Stock in Q1 2016 and held it in 28 quarters.
- Citadel Advisors's NRC Health Common Stock position peaked at $3.04M in Q2 2024.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.